These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 1336776)

  • 1. Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.
    Jonas JM; Coleman BS; Sheridan AQ; Kalinske RW
    J Clin Psychiatry; 1992 Dec; 53 Suppl():19-31; discussion 32-3. PubMed ID: 1336776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem: distinct from triazolam?
    Lobo BL; Greene WL
    Ann Pharmacother; 1997 May; 31(5):625-32. PubMed ID: 9161660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the safety profiles of benzodiazepine hypnotics.
    Roth T; Roehrs TA
    J Clin Psychiatry; 1991 Sep; 52 Suppl():38-41. PubMed ID: 1680124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of zopiclone and triazolam in patients with insomnia.
    Chaudoir PJ; Bodkin NL; O'Donnell J; Anderson A; Holland RL
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():21-7. PubMed ID: 2201727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
    Elie R; Frenay M; Le Morvan P; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():39-46. PubMed ID: 2201729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical hypnotic effects of zopiclone and triazolam.
    Autret E; Maillard F; Autret A
    Eur J Clin Pharmacol; 1987; 31(5):621-3. PubMed ID: 3549323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J; Ruel D; Maillard F; Bianchi M
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
    Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of zopiclone and pentobarbitone as hypnotics.
    Mello de Paula AJ
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():188-95. PubMed ID: 6765243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance.
    Uchiumi M; Isawa S; Suzuki M; Murasaki M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Aug; 20(3):123-30. PubMed ID: 11215153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective.
    Wheatley D
    Drug Saf; 1992; 7(2):106-15. PubMed ID: 1605897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zopiclone to geriatric patients. A parallel double-blind dose-response clinical trial of zopiclone as a hypnotic to geriatric patients - a study in a geriatric hospital.
    Dehlin O; Rundgren A; Börjesson L; Ekelund P; Gatzinska R; Hedenrud B; Mellström D
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():173-8. PubMed ID: 6765242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.
    Fontaine R; Beaudry P; Le Morvan P; Beauclair L; Chouinard G
    Int Clin Psychopharmacol; 1990 Jul; 5(3):173-83. PubMed ID: 2230061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zopiclone: a new nonbenzodiazepine hypnotic used in general practice.
    Monchesky TC; Billings BJ; Phillips R
    Clin Ther; 1986; 8(3):283-91. PubMed ID: 3521857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.